Skip to content

Fetal Intrapartum Heart Rate FHR/ECG Study

Fetal Intrapartum Heart Rate FHR/ECG Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01881685
Enrollment
400
Registered
2013-06-20
Start date
2013-03-31
Completion date
2015-12-31
Last updated
2019-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormality in Fetal Heart Rate or Rhythm

Brief summary

The objective of the study is to evaluate the association between certain markers in the blood of neonatal brain injury and specific Fetal Heart Rate monitoring findings using the device under study.

Detailed description

The purpose of the study is to: 1. evaluate the association between serologic markers of neonatal brain injury and the specific FHR monitoring findings using the investigational device; 2. investigate the relationship between selective serotonin reuptake inhibitor (SSRI) antidepressants and the QT interval of the fetal heart. Specifically, examine the potential association between maternal SSRI use and the fetal QT interval,and; 3. develop the capacity to measure uterine contractions during labor using non-invasive electrodes that measure the electrical signal from the uterine muscle. For this study, the investigational device will not be used to diagnose or treat as it will be used in concert with the current standard of care monitors.

Interventions

None listed

Sponsors

Mindchild Medical Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnant women in their third trimester and Women in labor (the progressive effacement and dilatation of the cervix) who are having their fetus' heart rate monitored continuously will form the eligible population for recruitment into our study * 18 years old or older * Women with the diagnosis of fetal intrauterine growth restriction may be included.

Exclusion criteria

* Speakers of languages other than English * Gestational age less than 24 weeks 0 days

Design outcomes

Primary

MeasureTime frameDescription
Quantitative FHR patterns predictive of adverse neonatal outcomeDuring Labor1)quantitative analysis of fetal heart-rate (FHR) data recorded during labor using advanced mathematical techniques, including pattern-recognition analysis using EKG stickers applied to the maternal abdomen.

Secondary

MeasureTime frameDescription
Uterine contraction measurementDuring LaborUterine contraction monitoring using skin surface electrodes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026